Steri-Strip tape after one-sided ectropion surgery
Postoperative Outcomes of Steri-Strip Surgical Tape Use in Unilateral Ectropion Surgery: A Parallel-Controlled Clinical Trial
This study will test whether using Steri-Strip tape after one-sided ectropion surgery helps adults heal with better eyelid appearance and function.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 74 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sanitas University Academic / other |
| Locations | 1 site (Bogotá) |
| Trial ID | NCT06935227 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial compares standard postoperative care with the addition of Steri-Strip tape on the operated eyelid in adults undergoing unilateral ectropion repair. Participants are randomized to receive Steri-Strip plus standard care or standard care alone and will be followed at 8 and 30 days after surgery. Measured outcomes include cosmetic appearance, eyelid position and function, and postoperative wound complications. Key exclusions include paralytic or cicatricial ectropion, connective tissue disorders causing skin hyperlaxity, and current isotretinoin use.
Who should consider this trial
Good fit: Adults (18 and older) scheduled for unilateral ectropion surgery who do not have paralytic or cicatricial ectropion, connective tissue disorders causing skin hyperlaxity, or current isotretinoin use.
Not a fit: Patients with paralytic ectropion, cicatricial ectropion from skin disease, connective tissue disorders like Ehlers-Danlos, or current isotretinoin use are excluded and unlikely to benefit from this approach.
Why it matters
Potential benefit: If successful, this simple, low-cost dressing could improve eyelid alignment and appearance, reduce wound problems, and simplify postoperative care.
How similar studies have performed: Steri-Strip use has been reported in case series and letters suggesting benefit in eyelid and facial procedures, but randomized trial evidence is lacking.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years or older who are scheduled to undergo unilateral ectropion surgery. Exclusion Criteria: * Underlying conditions associated with skin hyperlaxity, such as cutis laxa and Ehlers-Danlos syndrome. * Skin diseases that predispose to cicatricial ectropion, such as ichthyosis, scleroderma, and psoriasis. * Paralytic ectropion. * Current use of oral isotretinoin.
Where this trial is running
Bogotá
- Oftalmosanitas — Bogotá, Colombia (Recruiting)
Study contacts
- Principal investigator: Tatiana Gomez, MD — Unisanitas
- Study coordinator: Johana Benavides, MSc
- Email: jbenavidescr@unisanitas.edu.co
- Phone: 57 6015895377
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.